Earnings Outlook: Gilead and Amgen will report second-quarter earnings after the closing bell. Here’s what to expect

Drugmakers Gilead Sciences Inc. and Amgen Inc. are scheduled to report earnings Tuesday after the market close. Pharmaceutical companies have enjoyed a strong earnings season so far. Biogen Inc. BIIB, -1.53%, Bristol-Myers Squibb Co. BMY, -0.34%, AbbVie Inc. ABBV, -0.83%, Merck & Co Inc. MRK, -0.34% and Eli Lilly & Co. LLY, +0.24%  all topped…

3 Top Healthcare Stocks to Buy Right Now

These three healthcare stocks are worth checking out right now. Here’s why. George Budwell, Keith Speights, and Todd Campbell Healthcare stocks haven’t quite outperformed the broader markets this year, per usual, but they have performed admirably given all of the political headwinds facing the sector as a whole. The sector’s resilience during this politically turbulent…

Collision With Reality Sends Abeona Stock Spiraling Lower

There are many bad actors involved in Abeona who have a long history of shareholder value destruction We initially exposed Abeona for the low-quality biotech it is back in December 2016. We recommend readers refamiliarize themselves with our two reports on the company (here and here). To quickly summarize the original report: Abeona’s Chairman Steven…

Crash Protection For Altria

A reproduction of a sign by Altria’s Philip Morris brand (photo via Reedyville Goods). Biotech Beast Is An Altria Bear In a recent article (“Altria Becomes An Even More Compelling Short”), Seeking Alpha contributor Biotech Beast made a short case for Altria (MO) based in part on declining sales of traditional cigarettes and new regulatory…

Are You Afraid Of Being Left Behind By Industry 4.0? The World Economic Forum’s Global Lighthouse Network Can Help Light Your Way

Getty Radical leaps are being made in the development and application of digital industrial technologies and advanced manufacturing methods, collectively referred to as the Fourth Industrial Revolution, or Industry 4.0. These advances hold great promise for new solutions to common manufacturing challenges with workforces, business growth, and laws and regulations. […]

Global Blood Therapeutics: A Promising Biotech Pick In 2019

A cure for SCD (sickle cell disease) has long remained to be a far-fetched dream for the medical community. This is ironical, since for decades now, the medical fraternity is very well aware of the single gene mutation in the beta-chain of hemoglobin that leads to this hemoglobinopathy. The area remains woefully underserved, with very…